Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 4.05 is 22% above its 5-year average of 3.31, near the high end of its 5-year range (1.63–5.06).
As of the fiscal period ended Tuesday, March 31, 2026. 11.44% above its 12-month average of 3.63.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-03-31): 4.05.
CURRENT RATIO
4.05
CURRENT RATIO AVG TTM
3.63
CURRENT RATIO AVG 3Y
2.86
CURRENT RATIO AVG 5Y
3.31
CURRENT RATIO AVG 10Y
N/A
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+11.44%
CURRENT VS 3Y AVG
+41.63%
CURRENT VS 5Y AVG
+22.07%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.75
median of 874 covered companies
CURRENT VS SECTOR MEDIAN
+7.89%
vs the sector median at left
Universe Pharmaceuticals Inc.
Market Cap
$2.66M
Current Ratio
4.05
TTM Avg
3.63
3Y Avg
2.86
5Y Avg
3.31
Market Cap
$2.54M
Current Ratio
1.44
TTM Avg
1.74
3Y Avg
3.93
5Y Avg
2.64
Market Cap
$2.94M
Current Ratio
6.21
TTM Avg
4.42
3Y Avg
3.06
5Y Avg
2.22
Market Cap
$2.38M
Current Ratio
0.11
TTM Avg
0.75
3Y Avg
3.92
5Y Avg
2.68
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Universe Pharmaceuticals Inc. (UPC) | $2.66M | 4.05 | 3.63 | 2.86 | 3.31 |
| iSpecimen Inc. (ISPC)vs › | $2.69M | 0.82 | 0.87 | 1.93 | 3.50 |
| Nuwellis, Inc. (NUWE)vs › | $2.56M | 1.97 | 2.58 | 3.16 | 4.38 |
| bioAffinity Technologies, Inc. (BIAF)vs › | $2.54M | 1.44 | 1.74 | 3.93 | 2.64 |
| IceCure Medical Ltd (ICCM)vs › | $2.86M | 2.87 | 2.28 | 3.68 | 4.14 |
| Jaguar Health, Inc. (JAGX)vs › | $2.44M | 0.69 | 1.06 | 1.22 | 1.34 |
| Revelation Biosciences, Inc. (REVB)vs › | $2.94M | 6.21 | 4.42 | 3.06 | 2.22 |
| Moleculin Biotech, Inc. (MBRX)vs › | $2.38M | 0.94 | 1.19 | 3.93 | 6.93 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH)vs › | $2.38M | 0.11 | 0.75 | 3.92 | 2.68 |
| Onconetix, Inc. (ONCO)vs › | $2.37M | 2.21 | 0.36 | 1.94 | 12.76 |
Current Ratio
4.05
Quick Ratio
3.75
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-03-31 | 4.05 |
| 2025-09-30 | 4.07 |
| 2025-03-31 | 2.78 |
| 2024-09-30 | 2.54 |
| 2024-03-31 | 1.63 |
| 2023-09-30 | 2.68 |
| 2023-03-31 | 2.26 |
| 2022-09-30 | 3.17 |
| 2022-03-31 | 5.06 |
| 2021-09-30 | 4.50 |
| 2021-03-31 | 3.73 |
| 2020-09-30 | 2.91 |
| 2020-03-31 | 2.29 |
| 2019-09-30 | 2.24 |
| 2019-03-31 | 0.00 |
| 2018-09-30 | 1.19 |
| 2018-03-31 | 0.00 |
